Marie Vidailhet Selected Research

Tremor (Tremors)

1/2020	Brain 123I-FP-CIT SPECT of a Holmes Tremor Due to Midbrain Pilocytic Astrocytoma.
10/2017	New insight in spiral drawing analysis methods - Application to action tremor quantification.
9/2013	Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders.
11/2012	Tremor-spectrum in spinocerebellar ataxia type 3.
10/2012	FXTAS: new insights and the need for revised diagnostic criteria.
4/2011	Dystonic tremor caused by mutation of the glucose transporter gene GLUT1.
10/2008	Predominant cortical dysfunction in Guadeloupean parkinsonism.
10/2007	Myoclonus or tremor in orthostatism: an under-recognized cause of unsteadiness in Parkinson's disease.
6/2007	Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marie Vidailhet Research Topics

Disease

45	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2002
28	Dystonia (Limb Dystonia) 12/2021 - 02/2003
14	Parkinsonian Disorders (Parkinsonism) 01/2022 - 03/2006
12	Dystonic Disorders (Writer's Cramp) 09/2015 - 09/2007
9	Tremor (Tremors) 01/2020 - 06/2007
8	Myoclonic dystonia 01/2020 - 10/2002
7	Dyskinesias (Dyskinesia) 01/2022 - 02/2006
5	REM Sleep Behavior Disorder 01/2022 - 05/2011
5	Tourette Syndrome (Tourette's Syndrome) 01/2019 - 08/2010
5	Tics (Tic) 01/2017 - 08/2010
4	Movement Disorders (Movement Disorder) 01/2022 - 10/2008
4	Dementia (Dementias) 10/2020 - 10/2008
4	Myoclonus (Nocturnal Myoclonus) 05/2016 - 10/2007
3	Atrophy 01/2022 - 06/2007
3	Disease Progression 01/2020 - 01/2016
3	Hypokinesia (Bradykinesia) 11/2019 - 01/2011
3	Pain (Aches) 01/2017 - 06/2009
2	Synucleinopathies 01/2022 - 04/2016
2	Dystonia musculorum deformans type 1 12/2021 - 09/2021
2	Autonomic Nervous System Diseases (Dysautonomia) 10/2020 - 01/2018
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2020 - 12/2011
2	Cognitive Dysfunction 01/2019 - 01/2019
2	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2018 - 01/2018
2	Hallucinations (Hallucination) 01/2018 - 05/2011
2	Paralysis (Palsy) 01/2018 - 09/2013
2	Infections 01/2017 - 03/2007
2	Chorea (Rheumatic Chorea) 10/2012 - 11/2011
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 08/2010 - 10/2008
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Dysphonia (Spastic Dysphonia) 01/2021
1	Weight Gain 11/2020
1	Hemorrhage 01/2020
1	Astrocytoma (Pilocytic Astrocytoma) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Osteonecrosis (Kienbock's Disease) 12/2019
1	Osteomyelitis 12/2019
1	Alternating hemiplegia of childhood 10/2017
1	Deglutition Disorders (Dysphagia) 01/2017
1	Conversion Disorder (Astasia Abasia) 01/2017
1	Muscle Weakness 01/2017
1	Torticollis (Wryneck) 01/2017
1	Glut1 Deficiency Syndrome 01/2016
1	Hypersensitivity (Allergy) 01/2016
1	Sleepiness 11/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2015
1	Chromosomal Instability (Chromosome Stability) 09/2014
1	Mania (Manias) 04/2014

Drug/Important Bio-Agent (IBA)

20	Levodopa (L Dopa)FDA LinkGeneric 11/2020 - 08/2003
13	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 06/2005
7	neuromelaninIBA 01/2022 - 07/2013
6	Sarcoglycans (beta Sarcoglycan)IBA 01/2020 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2014
4	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2020 - 03/2006
4	Dihydroxyphenylalanine (Dopa)IBA 01/2019 - 10/2008
4	Antipsychotic Agents (Antipsychotics)IBA 02/2016 - 09/2010
3	Pharmaceutical PreparationsIBA 01/2021 - 06/2007
3	Dopamine Agonists (Dopamine Agonist)IBA 11/2020 - 05/2010
3	Neurotransmitter Agents (Neurotransmitter)IBA 11/2019 - 02/2003
3	Phosphotransferases (Kinase)IBA 11/2015 - 03/2007
3	Leucine (L-Leucine)FDA Link 11/2015 - 03/2007
2	Apomorphine FDA Link 01/2022 - 06/2021
2	Cholinergic Agents (Cholinergics)IBA 12/2021 - 01/2019
2	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 12/2021 - 09/2021
2	IronIBA 11/2021 - 07/2015
2	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 12/2018
2	Therapeutic UsesIBA 01/2018 - 09/2013
2	Zonisamide (Zonegran)FDA LinkGeneric 01/2018 - 05/2016
2	Botulinum Toxins (Botulinum Toxin)IBA 01/2017 - 01/2013
2	MelatoninIBA 01/2016 - 03/2010
2	Bee Venoms (Bee Venom)IBA 01/2016 - 01/2016
2	Methylphenidate (Ritalin)FDA LinkGeneric 05/2015 - 07/2012
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 05/2015 - 04/2002
2	Tetrabenazine (Nitoman)FDA Link 10/2012 - 04/2011
1	PrionsIBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 01/2022
1	alpha-SynucleinIBA 01/2022
1	propylene diquat (PDQ(+))IBA 01/2019
1	triheptanoinIBA 10/2017
1	TabletsIBA 10/2017
1	AnticoagulantsIBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	Glucose Transporter Type 1IBA 01/2016
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 12/2015
1	DNA Polymerase gammaIBA 06/2015
1	Fetal Proteins (Fetoprotein)IBA 09/2014
1	Immunoglobulins (Immunoglobulin)IBA 09/2014
1	Aminobutyrates (Aminobutyric Acid)IBA 05/2014

Therapy/Procedure

27	Deep Brain Stimulation 01/2022 - 08/2004
9	Therapeutics 01/2022 - 07/2009
3	Electrodes (Electrode) 01/2017 - 03/2007
3	Injections 01/2016 - 04/2011
3	Denervation 05/2015 - 09/2008
2	Transcranial Magnetic Stimulation 01/2017 - 09/2013
2	Operative Surgical Procedures 04/2014 - 08/2009
1	Radiotherapy 01/2020
1	Surgical Amputation (Amputations) 12/2019
1	Gastrostomy 10/2017
1	Contraindications 01/2017